This is because Mounjaro is not just a GLP-1 agonist because also contains a GIP agonist, having dual action in mimicking two key hormones involved in the regulation of insulin release and appetite
GLP-1 treatment can exert the direct action on reversing vascular remodeling by downregulating MMP1 expression via alleviating the ERK1/2/NF-B pathway in Ang II-induced rat aortic VSMCs [130]
PMOS causes insulin resistance, oestrogen levels start declining in your 40s, your appetite also sits at different points in your cycle
References Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1
Citrus Bottle effectively applies fat reduction treatments to both small and large areas, including the face and body
Lifestyle Factors Exercise, nutrition, sleep, and stress management all influence the rate of senescent cell accumulation and the body's capacity for tissue repair